Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Gestin

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Organon Wins MHRA Approval Extending Nexplanon Use to Five Years
    Organon Wins MHRA Approval Extending Nexplanon Use to Five Years

    21 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-21/organon-announces-mhra-approval-extending-duration-of-use-of-nexplanon-etonogestrel-implant-68-mg-radiopaque-to-five-years-1

    PHARMIWEB
    21 May 2026
    Share Share
    Hanmi Pharma Teams Up With Organon For Combo Therapy Exports
    Hanmi Pharma Teams Up With Organon For Combo Therapy Exports

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299069/0/en/hanmi-pharmaceutical-partners-with-organon-to-export-combination-therapies-to-southeast-asia.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Sun Pharma Explores Funding Mix For $12 Billion Organon Deal
    Sun Pharma Explores Funding Mix For $12 Billion Organon Deal

    06 May 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-explores-funding-mix-for-12-billion-organon-deal/articleshow/130841915.cms

    ECONOMICTIMES
    06 May 2026
    Share Share
    Organon Reports Results for First Quarter Ended March 31, 2026
    Organon Reports Results for First Quarter Ended March 31, 2026

    30 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260430180575/en/Organon-Reports-Results-for-the-First-Quarter-Ended-March-31-2026

    BUSINESSWIRE
    30 Apr 2026
    Share Share
    European Commission (EC) Approves Henlius And Organon's Poherdy
    European Commission (EC) Approves Henlius And Organon's Poherdy

    29 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/european-commission-ec-approves-henlius-and-organons-poherdy-pertuzumab-the-first-approved-biosimilar-to-perjeta-pertuzumab-in-europe-302757076.html

    PR NEWSWIRE
    29 Apr 2026
    Share Share
    EU Approves POHERDY as First Pertuzumab Biosimilar in Europe
    EU Approves POHERDY as First Pertuzumab Biosimilar in Europe

    29 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260429686426/en/European-Commission-EC-Approves-Henlius-and-Organons-POHERDY-pertuzumab-the-First-Approved-Biosimilar-to-PERJETA-pertuzumab-in-Europe

    BUSINESSWIRE
    29 Apr 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.